115,99 €
inkl. MwSt.
Versandkostenfrei*
Erscheint vorauss. 1. Juni 2025
payback
58 °P sammeln
  • Gebundenes Buch

Controlling Pharmaceutical Risks analyses changes in drug testing since the late 1990s, specifically geneticization of carcinogenic risk assessment and regulation of pharmaceuticals, involving issues fundamental to bio-science, medical treatment and patients' health, such as what knowledge is judged necessary to determine carcinogenic risk to humans, and how that judgement transpired.

Produktbeschreibung
Controlling Pharmaceutical Risks analyses changes in drug testing since the late 1990s, specifically geneticization of carcinogenic risk assessment and regulation of pharmaceuticals, involving issues fundamental to bio-science, medical treatment and patients' health, such as what knowledge is judged necessary to determine carcinogenic risk to humans, and how that judgement transpired.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.